National Pharmacy Health & Leadership Alliance Verify a MemberMember Login
NPHLANational Pharmacy Health & Leadership Alliance
Apply for Membership

03Aesthetics & LongevityWhat Changed TodayUpdated

What changed today in Aesthetics & Longevity: 6 trial updates, 5 new studies, 1 FDA announcement

Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.

By NPHLA IntelligencePublished Last updated Automated from official records

The signal

NPHLA tracked 12 new official records on this desk today: 6 trial updates, 5 new studies, 1 FDA announcement.

Why this matters

New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.

What changed

  1. New trial registered: AnteAGE Biosomes With Radiofrequency Microneedling for Facial Skin Rejuvenation[1]
  2. New trial registered: AnteAGE Exosomes and PEARL Multiplier With Microneedling for Facial Skin Quality[2]
  3. New trial registered: Evidence-Based Integrated Protocol to Maximize Hair Follicle Survival in Follicular Unit Extraction (FUE)[3]
  4. Results posted on ClinicalTrials.gov: A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)[4]
  5. Results posted on ClinicalTrials.gov: A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing[5]
  6. Results posted on ClinicalTrials.gov: A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia[6]
  7. New research in Materials today. Bio: “Skin organoid-derived exosomes in a hydrogel system potentiate skin wound healing”.[7]
  8. New research in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie: “Preparation of oxygen-filled adipose-derived stem cells exosome-nanobubbles gel for ultrasound-assisted full-thickness wound healing in rats”.[8]
  9. New research in Advanced healthcare materials: “PRP-Integrated Conductive Hydrogels With Dynamic Crosslinking for Accelerated Wound Healing and Physiological Monitoring”.[9]
  10. New research in Pakistan journal of pharmaceutical sciences: “TGα2β-modified adipose-derived stem cell exosomes regulate collagen synthesis in fibroblasts and enhance chronic ulcerative wound repair through the ILK/AKT signaling…”.[10]
  11. Plus 2 more official records today — browse the Aesthetics & Longevity desk feed for the full list.
  12. Also reported by Dermatology Times: “Dermatology FDA and Pipeline Review: Q3 2026 Approvals and Readouts”.[11]
  13. Also reported by Dermatology Times: “Alopecia Areata Awareness Month: 2026 in Review”.[12]
  14. Also reported by American Med Spa Association: “ValueCap Becomes Silver Vendor Affiliate with the American Med Spa Association”.[13]

Who this affects

  • Med spas
  • Medical directors
  • Prescribers
  • Practice owners & operators
  • Pharmacies

What to watch next

No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.

NPHLA takeaway

These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.

Source file

  1. [1]
  2. [2]
  3. [3]
  4. [4]
  5. [5]
  6. [6]
  7. [7]
  8. [8]
  9. [9]
  10. [10]
  11. [11]
    Dermatology FDA and Pipeline Review: Q3 2026 Approvals and Readouts

    News reportingDermatology TimesIndustry coverage — headline and link only

  12. [12]
    Alopecia Areata Awareness Month: 2026 in Review

    News reportingDermatology TimesIndustry coverage — headline and link only

  13. [13]
    ValueCap Becomes Silver Vendor Affiliate with the American Med Spa Association

    News reportingAmerican Med Spa AssociationIndustry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.

Update timeline

  1. First published.
  2. Added 5 new official records.
  3. Added 3 new official records.
  4. Added 1 new official record.